Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 9807 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Symbols and Colours by Pandora: Little Symbols of Big Dreams [8930-Views]
LG's Newest Innovations Earn Wide Range of Honors at Ces 2022 [8565-Views]
Sony World Photography Awards Announces Student and Youth Competitions 2022 Shortlists [3436-Views]
Amazon Joins Forces with MTE (MENATECH) to Expand Amazon UNIVERSITY Esports to UAE and KSA [3428-Views]
OMEGA Joins Satellite Clean-Up Mission [3317-Views]
Dubai Customs' Achievements in 2021 [3198-Views]
Aster DM Healthcare to Set Up its 6th Hospital in Kerala [3145-Views]
Republic of Paraguay; The Hidden Gem of South America Showcased Country's Eclectic Attract... [3132-Views]
2022 Ras Al Khaimah Half Marathon Adds World-class Runners to Elite Athlete Field and Reve... [3095-Views]
Dubai Shopping Malls Group's Up to 1 Million Dirhams Prized Weekly Raffles, a Hit With Sho... [3095-Views]
Ajman University Students Win The Excellence Award In Documentary Films [3026-Views]
Experts Behind Samsung's Newest Products and Technologies Discuss Innovating for the Futur... [2989-Views]
New Official Operational Hours Announced for Visa Application Centres in Abu Dhabi and Dub... [2936-Views]
Malabar Gold & Diamonds Continues Inauguration Spree with 3 New Showrooms Across Malaysia ... [2800-Views]
Etihad Expands Green Loyalty Offering With Corporate Programme to Reward Organisations and... [2726-Views]
Ring the New Year with Dubai Shopping Festival Deals from Nissan of Arabian Automobiles [2714-Views]
Go Down Memory Lane in New National Geographic Six-part Countdown Series, the ‘80s: Top Te... [2649-Views]
Samsung Electronics Joins Home Connectivity Alliance to Drive the Future of Connected Home... [2517-Views]
Festival Plaza Mall Collects Over 6000 Pre-Loved Toys in Partnership with Emirates Red Cre... [2501-Views]
St. George's University School of Medicine in Grenada Shares 10 Tips on Effective Studying [2480-Views]
Switzerland Hosts a Discussion on Innovative Solutions for Sustainable Water Use at the Sw... [2456-Views]
SEHA to host 2nd Abu Dhabi Integrated Mental Health Conference – A Boost to Mental Health ... [2394-Views]
Secretary General of Environment Agency – Abu Dhabi Highlights the Importance of Carbon Se... [2394-Views]
Saeed Hareb: Dubai Stage of UAE Tour to Start and Finish at Expo 2020 Dubai [2374-Views]
What if the Solution to Sleep Apnoea Syndrome was to be found at Arab Health 2022 ? [2353-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories